Skip to main content

Closed

ZNTL: Zentalis Pharmaceuticals, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

61thpctl

Volume

0.81×avg

Market Cap

337.42MUSD

P/E Ratio

-2.7TTM

Div Yield

-ann

Zentalis Pharmaceuticals, Inc.

ZNTLNASDAQ·USD·Closed

Zentalis Pharmaceuticals, Inc.

ZNTLNASDAQ·USD·Closed

$4.74

−3.66%

$4.74

−$0.18 (3.66%)

52W Range

61thpctl

Volume

0.81×avg

Mkt Cap

337.42MUSD

P/E

-2.7TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings